GB1538123A - Preparation for treatment of colitis - Google Patents

Preparation for treatment of colitis

Info

Publication number
GB1538123A
GB1538123A GB14390/76A GB1439076A GB1538123A GB 1538123 A GB1538123 A GB 1538123A GB 14390/76 A GB14390/76 A GB 14390/76A GB 1439076 A GB1439076 A GB 1439076A GB 1538123 A GB1538123 A GB 1538123A
Authority
GB
United Kingdom
Prior art keywords
colitis
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14390/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of GB1538123A publication Critical patent/GB1538123A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
GB14390/76A 1975-04-09 1976-04-08 Preparation for treatment of colitis Expired GB1538123A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504049A SE7504049L (sv) 1975-04-09 1975-04-09 Colonpreparation

Publications (1)

Publication Number Publication Date
GB1538123A true GB1538123A (en) 1979-01-10

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14390/76A Expired GB1538123A (en) 1975-04-09 1976-04-08 Preparation for treatment of colitis

Country Status (12)

Country Link
BE (1) BE840552A (xx)
DE (1) DE2614296A1 (xx)
DK (1) DK153376A (xx)
FI (1) FI56772C (xx)
FR (1) FR2306710A1 (xx)
GB (1) GB1538123A (xx)
IE (1) IE42793B1 (xx)
LU (1) LU74732A1 (xx)
NL (1) NL7603600A (xx)
NO (1) NO761101L (xx)
NZ (1) NZ180552A (xx)
SE (1) SE7504049L (xx)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432966A (en) * 1979-12-10 1984-02-21 Roussel-Uclaf Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a first layer containing microcrystalline cellulose which is coated with an enteric organic polymer coating
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
GB2220855A (en) * 1988-07-16 1990-01-24 Reckitt & Colmann Prod Ltd Use of polymers in treatment of inflammatory bowel disease
GB2222772A (en) * 1988-09-20 1990-03-21 Glaxo Group Ltd Pharmaceutical compositions containing ranitidine
US5525634A (en) * 1990-05-04 1996-06-11 Perio Products, Ltd. Colonic drug delivery system
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US10695363B2 (en) 2017-04-14 2020-06-30 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
DE527942T1 (de) * 1990-05-04 1994-03-03 Perio Prod Ltd System zur arzneistoffabgabe im colon.
DE9212938U1 (de) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim Calciumpolycarbophil-Zubereitung zur Einnahme hoher Wirkstoffdosen

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432966A (en) * 1979-12-10 1984-02-21 Roussel-Uclaf Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a first layer containing microcrystalline cellulose which is coated with an enteric organic polymer coating
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US5051253A (en) * 1988-07-16 1991-09-24 Reckitt & Colman Products Limited Use of polyacrylates to reduce proteolytic activity in the human intestinal tract
GB2220855A (en) * 1988-07-16 1990-01-24 Reckitt & Colmann Prod Ltd Use of polymers in treatment of inflammatory bowel disease
GB2220855B (en) * 1988-07-16 1992-01-22 Reckitt & Colmann Prod Ltd Use of polymeric compounds in treatment
GB2222772A (en) * 1988-09-20 1990-03-21 Glaxo Group Ltd Pharmaceutical compositions containing ranitidine
GB2222772B (en) * 1988-09-20 1992-05-13 Glaxo Group Ltd Pharmaceutical compositions
US5456918A (en) * 1988-09-20 1995-10-10 Glaxo Group Limited Ranitidine pharmaceutical compositions
US5525634A (en) * 1990-05-04 1996-06-11 Perio Products, Ltd. Colonic drug delivery system
US5866619A (en) * 1990-05-04 1999-02-02 Perio Products Ltd. Colonic drug delivery system
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US10695363B2 (en) 2017-04-14 2020-06-30 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders

Also Published As

Publication number Publication date
DE2614296A1 (de) 1976-10-21
NL7603600A (nl) 1976-10-12
FR2306710B1 (xx) 1979-07-13
NZ180552A (en) 1978-07-28
FR2306710A1 (fr) 1976-11-05
FI760948A (xx) 1976-10-10
DK153376A (da) 1976-10-10
FI56772B (fi) 1979-12-31
IE42793B1 (en) 1980-10-22
FI56772C (fi) 1980-04-10
BE840552A (fr) 1976-10-11
LU74732A1 (xx) 1977-02-04
SE7504049L (sv) 1976-10-10
NO761101L (xx) 1976-10-12
IE42793L (en) 1976-10-09

Similar Documents

Publication Publication Date Title
ZA765406B (en) Treatment of small articles
GR60854B (en) Preparation process of benzylidenic derivatives
GR59797B (en) Preparation process of thieno-pyridine derivatives
ZA764855B (en) Treatment of pigment
GR60835B (en) Preparation process of delta15-steroids
ZA764653B (en) Treatment of endotoxaemia
ZA763339B (en) Treatment of pigment
GB1538123A (en) Preparation for treatment of colitis
GR60435B (en) Preparation process of acylamino-derivatives
GB1554283A (en) Treatment of glass
GR60047B (en) Preparation process of 11-desoxy-16-aryloxy-omega-tetranorprostaglandins
JPS5251330A (en) Preparation of trichloromethyll trifluoromethyllbenzene
JPS51115427A (en) Preparation of ethylbenzole
JPS51131836A (en) Preparation of acetoacetylarylamide
GR60849B (en) Preparation process of l-pyroglutamyl-l-prolinamide
PT64945B (en) Preparation of therapeutic compounds
JPS5212976A (en) Treatment of unicellular preotein
ZA763340B (en) Treatment of pigment
IL49686A0 (en) Preparation of 3-phenoxybenzaldehydes
JPS5259118A (en) Preparation of trichloromethyll trifluoromethyllbenzene
JPS5218810A (en) Complex medical composition of estrogennprostaglangin
JPS5259119A (en) Preparation of trichloromethyll trifluoromethyllbenzene
IL50634A0 (en) Preparation of 2-amino-1-alcohols
ZA765733B (en) Treatment of effluent
PT65624A (en) Process of preparation of 4-hydroxymethyl-2-pyrrolidinone

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee